CareBright

CareBright.ie

CareBright is a long established Irish home care provider. Our focus is caring for and supporting people to live independently in their own homes. We have been providing services to the community since 1998 .We are a service provider for the HSE, in the form of Home Care Grants, Home Help Services, Chiropody, and Subsidised Hours in the home, while also providing care for clients in a private capacity.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BIOMICA ANNOUNCES THE ADVANCEMENT TO LARGE-SCALE PRODUCTION OF BMC128, ITS LIVE BACTERIAL PRODUCT CANDIDATE CONSORTIUM

Biomica | October 13, 2020

news image

Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today the advancement to large-scale production of BMC128, its Live Bacterial Product (LBP) candidate consortium. The microbes, which will be produced in large-scale are expected to support Biomica's first-in-man proof-of-concept clinical trials for its immuno-oncology program, anticipated to begin in 2021. BMC128 is advan...

Read More

RESEARCH SOLUTIONS ANNOUNCES PARTNERSHIP WITH BIO BUSINESS SOLUTIONS TO BRING ONE-CLICK SCIENTIFIC LITERATURE ACCESS TO THE BIOTECH INDUSTRY

Research Solutions | October 12, 2020

news image

Research Solutions/Reprints Desk (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, today announced that it has partnered with BIO Business Solutions to help life sciences companies save time and money on scholarly literature access via its award-winning Article Galaxy research platform. Operated by the Biotechnology Innovation Organization (BIO), BIO Business Solutions is the industry's largest cost savings purchasing program. More than 4...

Read More

CELL AND GENE THERAPY

MRNA VICTORIA AND GINKGO BIOWORKS ANNOUNCE PARTNERSHIP TO GROW THE BIOECONOMY & INTERNATIONAL BIOSECURITY CAPABILITIES

Ginkgo Bioworks, mRNA Victoria | November 18, 2021

news image

mRNA Victoria, the agency of the Australian State of Victoria Government charged with building the State's mRNA manufacturing and research capability, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced a partnership to support vaccine development, biosecurity initiatives, and the application to Ginkgo's platform in the pharmaceutical and biotech, food and agriculture, and mining and bioremediation/recycling sectors in Australia. As the first ...

Read More

DIVERSE BIOTECH ANNOUNCES ORPHAN-DRUG DESIGNATION FOR TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA

Diverse Biotech | May 04, 2020

news image

Diverse Biotech, Inc. www.diversebiotech.com has announced the U.S. Food & Drug Administration (FDA) has granted an orphan-drug designation request for one of its investigational new therapies for treatment of newly diagnosed glioblastoma, in conjunction with standard treatment, following adjuvant combined chemo-radiation. Orphan designation qualifies the sponsor of the drug for various development incentives of the ODA, (Orphan Drug Act) including tax credits for qualified clinical te...

Read More
news image

BIOMICA ANNOUNCES THE ADVANCEMENT TO LARGE-SCALE PRODUCTION OF BMC128, ITS LIVE BACTERIAL PRODUCT CANDIDATE CONSORTIUM

Biomica | October 13, 2020

Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today the advancement to large-scale production of BMC128, its Live Bacterial Product (LBP) candidate consortium. The microbes, which will be produced in large-scale are expected to support Biomica's first-in-man proof-of-concept clinical trials for its immuno-oncology program, anticipated to begin in 2021. BMC128 is advan...

Read More
news image

RESEARCH SOLUTIONS ANNOUNCES PARTNERSHIP WITH BIO BUSINESS SOLUTIONS TO BRING ONE-CLICK SCIENTIFIC LITERATURE ACCESS TO THE BIOTECH INDUSTRY

Research Solutions | October 12, 2020

Research Solutions/Reprints Desk (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, today announced that it has partnered with BIO Business Solutions to help life sciences companies save time and money on scholarly literature access via its award-winning Article Galaxy research platform. Operated by the Biotechnology Innovation Organization (BIO), BIO Business Solutions is the industry's largest cost savings purchasing program. More than 4...

Read More
news image

CELL AND GENE THERAPY

MRNA VICTORIA AND GINKGO BIOWORKS ANNOUNCE PARTNERSHIP TO GROW THE BIOECONOMY & INTERNATIONAL BIOSECURITY CAPABILITIES

Ginkgo Bioworks, mRNA Victoria | November 18, 2021

mRNA Victoria, the agency of the Australian State of Victoria Government charged with building the State's mRNA manufacturing and research capability, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced a partnership to support vaccine development, biosecurity initiatives, and the application to Ginkgo's platform in the pharmaceutical and biotech, food and agriculture, and mining and bioremediation/recycling sectors in Australia. As the first ...

Read More
news image

DIVERSE BIOTECH ANNOUNCES ORPHAN-DRUG DESIGNATION FOR TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA

Diverse Biotech | May 04, 2020

Diverse Biotech, Inc. www.diversebiotech.com has announced the U.S. Food & Drug Administration (FDA) has granted an orphan-drug designation request for one of its investigational new therapies for treatment of newly diagnosed glioblastoma, in conjunction with standard treatment, following adjuvant combined chemo-radiation. Orphan designation qualifies the sponsor of the drug for various development incentives of the ODA, (Orphan Drug Act) including tax credits for qualified clinical te...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us